T-cells are the immune system's frontline defenders with a crucial role in controlling HIV. In a milestone clinical trial ...

A multinational team led by Weill Cornell Medicine investigators developed a test that will help measure the persistence of HIV in people affected by viral strains found predominantly in Africa—a ...

Scientists have successfully zapped HIV out of infected cells — raising hopes of a cure for the chronic disease. The team from Amsterdam UMC used gene-editing technology to eliminate all traces of the ...

Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily dose of antiretroviral drugs. In one recent clinical ...

For years, researchers have been hoping for vaccines that protect people against not just one strain of HIV, but every strain of the quickly mutating virus. This requires a vaccine that coaxes the ...

There are two types of HIV: 1 and 2 , and each has several groups and strains. HIV-1 is the most common type that impacts people worldwide, according to WebMD. This new strain belongs to HIV-1 Group M ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Delivering a single shot of gene therapy at birth could offer children ...

Of the 40 million people infected worldwide with HIV, more than 70 percent live in Africa. Yet a new study suggests a key component in current therapies could be less effective on African forms of the ...

Drug-resistant strains of HIV could become more prevalent - even developing into mini-epidemics - in San Francisco over the next five years as patients live longer, healthier lives, according to a ...

The meeting comes after the US said it plans to cut HIV/AIDS funding for the country, where rates are the highest in the ...